Stage IV ALK Lung Cancer: Frank's Survivor Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Biomarkers
- ALK-positive
- Sex
- Male
- Treatment
- targeted therapy, surgery and radiation
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- A first ALK tyrosine kinase inhibitor reduced the tumor enough for lobectomy; brain radiation was also part of treatment; a second ALK tyrosine kinase inhibitor maintained disease-free status for more than 7 years.
What happened, in summary
Frank Sierawski was diagnosed with Stage IV lung cancer in his 30s, when his three children were six, four, and two. The diagnosis affected the entire family. His children were young enough to remember little of the treatment, while his wife Kathryn carried vivid memories of surgery, brain radiation, uncertainty, and planning for the possibility that their time together might be short.
Testing found that Frank’s cancer was ALK-positive. The first ALK tyrosine kinase inhibitor reduced the tumor enough for him to undergo a lobectomy. He later moved to a second ALK-targeted treatment, which kept him disease-free for more than seven years. His doctor’s willingness to speak about aiming for a cure gave the family hope even when that outcome seemed unlikely.
Reaching milestones he once feared he would miss changed the meaning of Father’s Day for Frank. Rather than focusing on being celebrated for one day, he valued the time available to watch his children grow, graduate, and pursue their interests. Moving from a Stage IV diagnosis to years without detectable disease pushed him to create memories deliberately and to begin living fully without waiting for a more certain future.
Where this story comes from
This is a lay summary of an account first published by LUNGevity. Read the original in full
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team.